ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677066; 2) Community: the network communities that were significantly associated with the response to NSC 677066; 3) Molecule: the relationships between components within communities and NSC 677066; 4) MDR: the compounds that were significantly associated with the NSC 677066.

NSC Compound Enrichment Correlation
NSC 268251 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE 0.0119221520283057 -0.21573657
NSC 630703 Acridomide 0.0119221520283057 0.21607165
NSC 658228 Null 0.0119221520283057 0.1339817
NSC 668482 Null 0.0119221520283057 0.025806647
NSC 677617 Furan-2,3-dione, tetrahydro-4-acetoxy- 4-(1-phenyl-2-propen-1-yl)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)- 0.0119221520283057 0.1233324
NSC 682450 Benzo[1,2-b:4,5-b']dithiophene-4,8-dione, 2-[1-(acetyloxy)ethyl]- 0.0119221520283057 0.60597783
NSC 698048 Null 0.0119221520283057 0.27393698
NSC 720872 3-(3-Hydroxy-4-methoxybenzyl)-5,7-dihydroxychroman-4-one 0.0119221520283057 0.55108396
NSC 729133 Null 0.0119221520283057 0.49381881
NSC 731154 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno [1,2-c]isoquinoline 0.0119221520283057 0.34388856
Total:67  Current:19    [First] [Prev] [Next] [Last]